# The Effect of ASTARTE™ on Recurrent Urinary Tract Infection

> **NCT05553652** · NA · RECRUITING · sponsor: **Hvidovre University Hospital** · enrollment: 720 (estimated)

## Conditions studied

- Recurrent Urinary Tract Infection

## Interventions

- **DIETARY_SUPPLEMENT:** ASTARTE™ oral capsules
- **DIETARY_SUPPLEMENT:** Placebo oral capsules

## Key facts

- **NCT ID:** NCT05553652
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-19
- **Primary completion:** 2024-08-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 720 (ESTIMATED)
- **Last updated:** 2022-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05553652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05553652, "The Effect of ASTARTE™ on Recurrent Urinary Tract Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05553652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*